首页> 外文OA文献 >High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation

【2h】

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation

机译：在疾病表现时，PRAME表达水平的高低（而非中等）不是骨髓增生异常综合征的不良预后标志

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Liberante FG; Pellagatti A; Boncheva V; Bowen DT; Mills KI; Boultwood J; Guinn B-A;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation [J] . LiberanteF.G., PellagattiA., BonchevaV., British Journal of Haematology . 2013,第2期

机译：在疾病表现时，PRAME表达水平的高低（而非中等）不是骨髓增生异常综合症的不良预后指标
2. PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes [J] . QinY.-Z., ZhuH.-H., LiuY.-R., Leukemia and lymphoma . 2013,第7期

机译：PRAME和WT1转录本构成了一种良好的分子标记组合，可用于监测骨髓增生异常综合症的最小残留病
3. Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion. [J] . Oliva EN, Cuzzola M, Nobile F, European Journal of Haematology . 2010,第3期

机译：来那度胺治疗过程中伴有5q染色体缺失的低危和中危1型骨髓增生异常综合征患者RPS14表达水平的变化。
4. Ras gene mutation in acute myeloid leukemia and Myelodysplastic syndromes: a meta-analysis of its occurrence and prognostic relevance [C] . Cheng Jingru, Wang Peng, Zhang Tai, International Conference on Advanced Materials and Computer Science . 2016

机译：RAS基因突变在急性髓性白血病和髓细胞增强综合征中：荟萃分析其发生和预后相关性
5. Myelodysplastic Syndrome Progression to Acute Myeloid Leukemia at the Stem Cell Level [D] . Chen, Jiahao. 2018

机译：在干细胞水平上骨髓增生异常综合征进展为急性髓细胞性白血病
6. Overexpression of WT1 and PRAME predicts poor outcomes of patients with myelodysplastic syndromes with thrombocytopenia [O] . Qiu-Sha Huang, Jing-Zhi Wang, Ya-Zhen Qin, 2019

机译：WT1和PRAME的过表达预测患有血小板减少症的骨髓增生异常综合症患者的预后不良
7. High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation. [O] . Liberante FG, Pellagatti A, Boncheva V, 2013

机译：在疾病表现时，PRAME表达水平的高低（而非中等）不是骨髓增生异常综合症的不良预后指标。
8. Analysis of microRNA Expression in the Myelodysplastic Syndromes Using Hematopoietic Stem Cells. [R] . Chung, S. 2015

机译：用造血干细胞分析骨髓增生异常综合征中microRNa的表达。

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation

著录项

引文网络

相似文献

相关主题

期刊订阅